Literature DB >> 22180471

Beyond "cirrhosis": a proposal from the International Liver Pathology Study Group.

Prodromos Hytiroglou1, Dale C Snover, Venancio Alves, Charles Balabaud, Prithi S Bhathal, Paulette Bioulac-Sage, James M Crawford, Amar P Dhillon, Linda Ferrell, Maria Guido, Yasuni Nakanuma, Valerie Paradis, Alberto Quaglia, Neil D Theise, Swan N Thung, Wilson M S Tsui, Dirk J van Leeuwen.   

Abstract

"Cirrhosis" is a morphologic term that has been used for almost 200 years to denote the end stage of a variety of chronic liver diseases. The term implies a condition with adverse prognosis due to the well-known complications of portal hypertension, hepatocellular carcinoma, and liver failure. However, recent advances in the diagnosis and treatment of chronic liver diseases have changed the natural history of cirrhosis significantly. This consensus document by the International Liver Pathology Study Group challenges the usefulness of the word cirrhosis in modern medicine and suggests that this is an appropriate time to consider discontinuing the use of this term. The role of pathologists should evolve to the diagnosis of advanced stage of chronic liver disease, with emphasis on etiology, grade of activity, features suggestive of progression or regression, presence of other diseases, and risk factors for malignancy, within the perspective of an integrated clinicopathologic assessment.

Entities:  

Mesh:

Year:  2012        PMID: 22180471     DOI: 10.1309/AJCP2T2OHTAPBTMP

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  30 in total

Review 1.  Management before hepatectomy for hepatocellular carcinoma with cirrhosis.

Authors:  Hisashi Nakayama; Tadatoshi Takayama
Journal:  World J Hepatol       Date:  2015-09-18

2.  Strain elastography for noninvasive assessment of liver fibrosis: A prospective study with histological comparison.

Authors:  Cheng Fang; Sanjiv Virdee; Joseph Jacob; Olivia Rufai; Kosh Agarwal; Alberto Quaglia; Daniel J Quinlan; Paul S Sidhu
Journal:  Ultrasound       Date:  2019-07-23

Review 3.  Staging of liver fibrosis or cirrhosis: The role of hepatic venous pressure gradient measurement.

Authors:  Ki Tae Suk; Dong Joon Kim
Journal:  World J Hepatol       Date:  2015-03-27

4.  Non invasive tools for the diagnosis of liver cirrhosis.

Authors:  Maurizio Soresi; Lydia Giannitrapani; Melchiorre Cervello; Anna Licata; Giuseppe Montalto
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

5.  Evaluating the risk of hepatocellular carcinoma in patients with prominently elevated liver stiffness measurements by FibroScan: a multicentre study.

Authors:  Maciej Adler; Licia Larocca; Francesca M Trovato; Heather Marcinkowski; Yasmin Pasha; Simon D Taylor-Robinson
Journal:  HPB (Oxford)       Date:  2016-06-09       Impact factor: 3.647

6.  Vascular liver lesions: contemporary views on long-recognized entities.

Authors:  Christine Sempoux; Paulette Bioulac-Sage
Journal:  Virchows Arch       Date:  2018-03-14       Impact factor: 4.064

7.  Delayed Diagnosis of HCC with Chronic Alcoholic Liver Disease.

Authors:  Kerstin Schütte; Jan Bornschein; Stefan Kahl; Ricarda Seidensticker; Jörg Arend; Jens Ricke; Peter Malfertheiner
Journal:  Liver Cancer       Date:  2012-11       Impact factor: 11.740

Review 8.  Pattern and profile of chronic liver disease in acute on chronic liver failure.

Authors:  Zaigham Abbas; Lubna Shazi
Journal:  Hepatol Int       Date:  2015-05-28       Impact factor: 6.047

9.  qFibrosis: a fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients.

Authors:  Shuoyu Xu; Yan Wang; Dean C S Tai; Shi Wang; Chee Leong Cheng; Qiwen Peng; Jie Yan; Yongpeng Chen; Jian Sun; Xieer Liang; Youfu Zhu; Jagath C Rajapakse; Roy E Welsch; Peter T C So; Aileen Wee; Jinlin Hou; Hanry Yu
Journal:  J Hepatol       Date:  2014-02-26       Impact factor: 25.083

Review 10.  Regression of human cirrhosis: an update, 18 years after the pioneering article by Wanless et al.

Authors:  Prodromos Hytiroglou; Neil D Theise
Journal:  Virchows Arch       Date:  2018-03-27       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.